NIH Locks Doors for Secret Science Funding Talks
Published Date: 2/17/2026
Notice
Summary
The NIH’s Center for Scientific Review is holding several closed virtual meetings in March 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists applying for grants in population studies, Alzheimer’s, and cancer research should note these important review dates.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
NIH peer-review meetings scheduled in March
The NIH Center for Scientific Review will hold virtual meetings to review grant applications on specific March 2026 dates: March 13; March 17-18; March 18; and March 18-19. These panels review applications in areas including population sciences and epidemiology, Alzheimer's disease and related dementias, translational cancer research (SPORE P50), IDeA CTR-D (P20/P50), big data/health IT/clinical informatics, healthcare delivery and disparities, and infectious disease molecular virology.
Reviews closed to protect trade secrets and privacy
The meetings will be closed to the public under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, commercial property (such as patentable material), and personal information tied to grant applications. If you are an applicant, expect that discussions of your application may be held in a closed virtual meeting to protect proprietary and private information.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06501 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a cool new invention—special human antibodies that can fight certain cancers and autoimmune diseases—for companies to license and develop into treatments. This means businesses can jump on this opportunity to create powerful new medicines using government-backed research. Interested parties should act soon and may need to sign agreements to get full details.
2026-06283 — Prospective Grant of an Exclusive Patent License: Pigment Epithelium-Derived Factor (PEDF) Peptides and Use for Treating Retinal Degeneration
The National Eye Institute plans to give Perpetual Biosciences, Inc. an exclusive license to use special PEDF peptides to treat eye diseases that cause vision loss. This means the company will have the sole right to develop and sell this promising treatment, potentially helping millions with retinal degeneration. If you want to comment or apply for a license, act fast—submissions close April 16, 2026!
2026-05957 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in April 2026 to review and decide on important research grant applications. These meetings affect scientists seeking funding in areas like neuroscience, cancer, and liver disease. No public access is allowed to protect private info and trade secrets, and these reviews help decide where millions in research money will go.
2026-05672 — National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings
The National Institute on Deafness and Other Communication Disorders is holding two closed meetings in late April and early May 2026 to review grant applications and evaluate researchers’ qualifications. These meetings affect scientists seeking funding and help ensure top-notch research gets supported. No public access means privacy is protected, and the process keeps the money flowing to the best projects on time.
2026-05673 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on April 17, 2026, to review and evaluate important grant applications in health and science fields. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-05738 — Submission for OMB Review; 30-Day Comment Request; National Institutes of Health (NIH) Loan Repayment Programs, (Office of the Director)
The NIH is asking for a 30-day public comment on extending its Loan Repayment Programs that help doctors and scientists pay off their student loans while they do important health research. This extension keeps the program running smoothly with no big changes, and comments are due by April 23, 2026. If you’re a researcher with student loans, this program could save you money while you help improve health!
Previous / Next Documents
Previous: 2026-03027 — Agency Information Collection Activities; Comment Request; Federal Perkins Loan Program Regulations and General Provisions Regulations
The Department of Education wants to keep collecting info for the Federal Perkins Loan Program without changing anything. This affects students, schools, and loan managers who handle these loans. You’ve got until April 20, 2026, to share your thoughts, but no new costs or rules are coming—just a smooth extension of the current process.
Next: 2026-03030 — National Institute on Minority Health and Health Disparities; Cancellation of Meeting
Heads up! The National Institute on Minority Health and Health Disparities has canceled its big meeting planned for March 27, 2026, in Bethesda, MD. If you were planning to attend or follow along, there won’t be a new date, so mark your calendars accordingly. No money changes or delays—just a simple cancellation to keep you in the loop!
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in